jetcityimage UnitedHealth (NYSE:UNH) is the world’s largest health insurance company, offering a full range of health benefits and operating Optum health services business that serves the broad healthcare marketplace. UnitedHealth has been leveraging its strong balance sheet to pursue both large and small acquisitions, consolidating the market and expanding their data analytics business. As I believe the stock price is undervalued, I am initiating a ‘Strong Buy’ rating with a one-year target price of $7 ...

PARAGUAY - 2024/08/19: In this photo illustration, the UnitedHealth Group logo is displayed on a ... [+] smartphone screen. (Photo Illustration by Jaque Silva/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesUnitedHealth stock (NYSE: UNH) has gained 80% in value since early January 2021 – jumping from levels of $335 then to around $600 now – vs. an increase of about 45% for the S&P 500 over this period. This can primarily be attributed to a significant 48% rise in the company ...

Wolterk Written by Nick Ackerman It has been quite some time since we've taken a focused look at UnitedHealth Group (NYSE:UNH), a healthcare behemoth with a market cap of nearly $550 billion. Since our prior update, shares have performed fairly modestly relative to the broader market. That was just over two years ago, and I had a more neutral stance on the name, with a 'Hold' rating. These gains only came about more recently, too, as the share price started moving higher after their latest earnings. UNH Per ...

UnitedHealth Group (UNH) closed the latest trading day at $594.10, indicating a -0.47% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.16%. Meanwhile, the Dow gained 1.2%, and the Nasdaq, a tech-heavy index, added 1.16%.Shares of the largest U.S. health insurer have appreciated by 6.82% over the course of the past month, outperforming the Medical sector's gain of 4.5% and the S&P 500's gain of 3.48%.Analysts and investors alike will be keeping a clos ...

UnitedHealth is a solid dividend stock that you can buy and forget about.Are you looking for a good dividend stock to own? You might want to take a closer look at UnitedHealth Group (UNH -1.44%). It's a top healthcare company to invest in, and while its yield may not look all that high, it can make for a solid investment, especially if you hang on to it for the long term.There are plenty of great reasons why dividend investors should buy this underrated stock today. Here are three worth mentioning:1. United ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about UnitedHealth Group (UNH) .UnitedHealth currently has an average brokerage ...

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.One of our most popular services, Zacks Premium offers daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All are useful tools to find what stocks to buy, what to sell, and what are today's hottest industries.Also ...

公司股票表现 - 联合健康集团(UNH)股价在过去三个月上涨15.1% 超过行业12.2%的涨幅 也超过标准普尔500指数5.9%的涨幅[1] - 目前股价为584.51美元 仅比52周高点低1.2% 且高于50日和200日移动平均线 显示出强劲的上涨势头[1] 公司业务前景 - 国内医疗支出上升且疾病病例增加 公司业务组合多样 能利用增长需求抵消私人医疗保险计划费率降低导致的利润率低于预期的影响[2] - 公司预计医疗补助计划持续增长 巴西业务的剥离虽短期影响小 但长期可释放现金提高盈利能力[2] - 公司通过拓展家庭医疗保健和分析业务来多元化业务组合 利用AI等工具扩大业务规模 降低长期成本并提高整体效率[3] 公司股东回报 - 2024年上半年 通过股票回购和股息向股东返还67亿美元 股息收益率为1.44% 高于行业平均的1.31% 自2010年以来持续提高股息[3] 公司盈利预期 - 2024年调整后每股净收益预计在27.50 - 28.00美元 中间值较2023年增长10.5%[4] - 2024年调整后每股收益的扎克斯共识估计为27.69美元 同比增长10.2% 2025年预计进一步增长12.7% 2024和2025年营收预计同比分别增长7.3%和8.2% 过去四个季度均超出盈利预期 平均超出3.3%[5] 公司面临挑战 - 美国监管机构维持2025年私人医疗保险计划费率 预计会降低公司该业务的盈利能力 其他保险公司也会受影响 行业面临医疗成本上升压力[6] - 2023年公司医疗护理比率平均为83.2% 2024年第一季度升至84.3% 第二季度为85.1% 国际业务会员减少影响保费增长[7] - 健康服务部门Optum受网络攻击影响 估计损失约16亿美元 美国卫生与公众服务部将调查潜在违反患者数据保护法的行为 还将增加网络安全支出[7] 公司估值情况 - 从估值角度看 公司股票的远期市盈率为19.50X 高于其五年中位数18.96X和行业平均的16.97X[8] 公司投资建议 - 现有股东可继续持有股票 潜在投资者可能需要等待公司解决费用上升问题且估值更有利时再考虑入场 目前股票扎克斯评级为3(持有)[10]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?The Zac ...

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. All of the features can help you identify what stocks to buy, what to sell, and what ...